Biomedical Engineering (BME)

Biomedical Engineering (BME)

Biomedical Engineering (BME)

The Department of Biomedical Engineering is one of the fastest growing departments in the nation providing solutions to global challenges of today and tomorrow to improve quality of life. Anchored by our innovative and challenging undergraduate and graduate curricula, we offer fundamental and applied engineering education that trains graduates to succeed in diverse areas of the field. Novel research and solutions to real-world problems are cornerstones of our educational programs which lead to new knowledge, therapies, and devices and well-prepared students ready to positively impact the world.

Rowan BME inventors receive Edison Patent Award for back pain treatment

Dr. Anthony Lowman, Provost and Senior Vice President for Academic Affairs, and Dr. Erik Brewer, a Senior Lecturer in the Henry M. Rowan College of Engineering, won the prestigious award for their U.S. patent, “Cross-Linked Hydrogels and Methods of Making the Same.” In recent clinical trials, patients reported their chronic pain levels decreased by more than 80% at three months.

New graduate student exchange and collaboration with SETU, Ireland

“The best advances in science and engineering come as a result of collaboration and sharing of expertise,” said Mark Byrne, founding dean of the School of Translational Biomedical Engineering and Sciences of Rowan University. “This graduate student exchange program will certainly attract the brightest minds in our fields, and in the long term, it will build professional relationships that will greatly benefit our two countries. Choose New Jersey’s efforts to introduce New Jersey companies and higher education institutions abroad will lead to new discoveries that will pay great dividends for all involved.”

Rowan University developing better treatment options for pediatric cancer

A recent $500,000 grant awarded by the N.J. Commission on Cancer Research in the New Jersey Department of Health will support research at Rowan University to develop less invasive and more personalized treatment options for pediatric acute myelogenous leukemia (AML). The project will be led by Rachel Riley, Ph.D., an assistant professor in the Department of Biomedical Engineering.